AF
HBIO icon

Advisornet Financial’s Harvard Bioscience HBIO Stock Holding History

Advisornet Financial’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10
Closed – – 1735
2020
Q3 		$0 Hold
10
– – ﹤0.01% 1780
2020
Q2 		$0 Hold
10
– – ﹤0.01% 1834
2020
Q1 		$0 Hold
10
– – ﹤0.01% 1840
2019
Q4 		$0 Hold
10
– – ﹤0.01% 1908
2019
Q3 		$0 Buy
+10
New +$249 ﹤0.01% 1892

Other funds holding HBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

Advisornet Financial's HBIO Position: Q4 2020 in Review

Advisornet Financial sold out of Harvard Bioscience (HBIO) in Q4 2020, closing a stake of 10 shares.

Advisornet Financial first reported a position in HBIO in Q3 2019 and held it in 5 quarters. The position peaked at $0 in Q3 2020. 81 funds tracked by Wall St. Rank hold HBIO as of Q4 2020.

  • Advisornet Financial reported no remaining Harvard Bioscience position as of Q4 2020 after selling out during the quarter.
  • Advisornet Financial sold 10 Harvard Bioscience shares in Q4 2020.
  • Advisornet Financial first reported a position in Harvard Bioscience in Q3 2019 and held it in 5 quarters.
  • Advisornet Financial's Harvard Bioscience position peaked at $0 in Q3 2020.
  • 81 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2020.

Based on Advisornet Financial's 13F filing for Q4 2020, filed 4 Feb 2021.